Cargando…

Nogo-A regulates myogenesis via interacting with Filamin-C

Among the three isoforms encoded by Rtn4, Nogo-A has been intensely investigated as a central nervous system inhibitor. Although Nogo-A expression is increased in muscles of patients with amyotrophic lateral sclerosis, its role in muscle homeostasis and regeneration is not well elucidated. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, SunYoung, Park, Ji-Hwan, Kang, Un-Beom, Choi, Seong-Kyoon, Elfadl, Ahmed, Ullah, H. M. Arif, Chung, Myung-Jin, Son, Ji-Yoon, Yun, Hyun Ho, Park, Jae-Min, Yim, Jae-hyuk, Jung, Seung-Jun, Kim, Sang-Hyup, Choi, Young-Chul, Kim, Dae-Seong, Shin, Jin-Hong, Park, Jin-Sung, Hur, Keun, Lee, Sang-Han, Lee, Eun-Joo, Hwang, Daehee, Jeong, Kyu-Shik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791112/
https://www.ncbi.nlm.nih.gov/pubmed/33414425
http://dx.doi.org/10.1038/s41420-020-00384-x
Descripción
Sumario:Among the three isoforms encoded by Rtn4, Nogo-A has been intensely investigated as a central nervous system inhibitor. Although Nogo-A expression is increased in muscles of patients with amyotrophic lateral sclerosis, its role in muscle homeostasis and regeneration is not well elucidated. In this study, we discovered a significant increase in Nogo-A expression in various muscle-related pathological conditions. Nogo(−/−) mice displayed dystrophic muscle structure, dysregulated muscle regeneration following injury, and altered gene expression involving lipid storage and muscle cell differentiation. We hypothesized that increased Nogo-A levels might regulate muscle regeneration. Differentiating myoblasts exhibited Nogo-A upregulation and silencing Nogo-A abrogated myoblast differentiation. Nogo-A interacted with filamin-C, suggesting a role for Nogo-A in cytoskeletal arrangement during myogenesis. In conclusion, Nogo-A maintains muscle homeostasis and integrity, and pathologically altered Nogo-A expression mediates muscle regeneration, suggesting Nogo-A as a novel target for the treatment of myopathies in clinical settings.